Newsletter march,12 2024

World Glaucoma Week 2024:

You Might Have It and Not Know!

Glaucoma, known as the silent thief of sight, silently damages the optic nerve—the cable that transfers images from the eye to the brain—without causing any noticeable symptoms such as pain, heaviness, or visual disturbances.

You might have it and not know. Even just before the complete loss of sight, patients may not realize it, posing a danger to themselves and others (e.g., while driving).

Even if you don't have glaucoma, the nerve fibers of your optic nerve die at an accelerated rate. We are born with around 1,000,000 nerve fibers in our optic nerve, and we progressively lose more than 4,000 every year. This means that even a healthy individual aged 75-80 has lost one-third of their optic nerve, significantly weakening their vision.

And it's irreversible. Like any other nerve in the central nervous system, the optic nerve cannot regenerate with any current method.

Until now, nerve regeneration within the central nervous system has proven unattainable, leaving conditions like glaucoma and spinal injuries without a cure.

That is why we created GENORASIS™, a revolutionary gene therapy company focused on developing a breakthrough treatment for nerve regeneration, with our initial focus on addressing glaucoma.
Our cutting-edge gene therapy aims to regenerate the damaged optic nerve while simultaneously providing neuroprotection.

Our goal is for patients to experience vision improvement and regain lost sight.

Doctor Niko Papazoglou M.D., an experienced eye surgeon and the CEO and co-founder of GENORASIS™, sheds light on the significance of World Glaucoma Week and urges investors to seize the opportunity to invest.

Dr. Papazoglou: --During World Glaucoma Week, our focus intensifies on the urgent need for innovative solutions to combat this silent thief of sight and the inevitable weakening of vision that comes with age.

As we raise awareness about the impact of glaucoma on millions worldwide, we also highlight the tremendous opportunity for investors to join us in pioneering breakthroughs in gene therapy for optic nerve regeneration.

Together, we have the power to transform lives, restore vision, and drive lucrative returns on investment. Join us in the fight against glaucoma and secure a brighter future for all.

Liz Parrish, MBA, COO, and co-founder of GENORASIS™, stands as one of the most prominent figures in the global longevity community. As the first human to receive gene therapies to treat the effects of aging, she urges investors to direct their attention
towards combating aging diseases.

Liz Parrish: --Why longevity? In prioritizing longevity, we are acknowledging the profound impact that extending our lifespans can have on our ability to witness and participate in the unfolding of technological advancements.

By prioritizing our health and well-being, we ensure that we have the opportunity to experience the full spectrum of innovations that humanity is poised to achieve. From breakthroughs in artificial intelligence to advancements in space exploration, the journey of technological evolution is one that we aspire to witness in its entirety.

Therefore, embracing longevity becomes not just a personal goal but a collective endeavor to maximize our potential and contribute to the future of technological progress.

Don't just sit there waiting for the inevitable. Do something NOW.

By prioritizing health and longevity, we gain not only the means but also the time and vitality to pursue all other endeavors, unhindered by the limitations of aging and illness.

What good is having everything you wish for if you can't see due to the silent thief of sight, or walk due to a dreadful accident on the road?

Today, these conditions may seem irreversible, but there is a way out of them. Breakthroughs in medical science are offering hope where there was once despair.

Is Investing in Regenerative Medicine and Gene Therapies a Profitable Decision?

Nothing is more important than health for an individual, but here we don't just talk about health problems, but also function. Being able to see, walk, and hear—all functions controlled by our central nervous system.

People with severe visual problems would give anything to regain sight, just as those with mobility limitations would do anything to regain the ability to walk. Because of that, investing in regenerative medicine and gene therapies not only makes a difference in people's lives but also positions you for financial success.

Ask for more information and we will send you our basic material for your review.